1. Dr. David C. Stump Appointed to REGENXBIO Board of Directors

    Dr. David C. Stump Appointed to REGENXBIO Board of Directors

    ROCKVILLE, Md. -- REGENXBIO Inc. , a leading biotechnology company in gene therapy, today announced the appointment of David C. Stump, M.D., to its board of directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. David's expertise in clinical research and development, as well as his experience advancing therapies through the regulatory process to FDA approval, will be of great value as REGENXBIO prepares to advance gene therapy treatments into the clinic.
    2. REGENXBIO's proprietary NAV Technology Platform has generated gene therapy treatments with the potential to transform the lives of patients suffering from severe diseases with significant unmet medical needs.
  3. Topics Mentioned